Beacon Biosignals is dedicated to accelerating innovation to get life-changing treatments to patients faster by unlocking the power of brain data to transform how neurological, psychiatric, and sleep disorders are diagnosed, treated, and understood using AI-powered sleep EEG analytics and neurotechnology.

Our FDA-cleared headband collects high-fidelity sleep EEG data at home or clinical settings, securely uploaded to the Beacon Platform where advanced AI models analyze brain function across individuals and populations. Our platform supports clinical-grade sleep EEG capture, low-latency event monitoring, and full-service clinical trial support to advance neuroscience innovation.

The platform helps identify dose-dependent drug effects, characterize patient populations, support label expansion, and track disease progression early for neurological and psychiatric conditions.

Beacon's leadership team includes experts with extensive backgrounds in neuroscience, machine learning, clinical operations, and biopharma. With offices in Boston, Paris, New York, and remote locations, Beacon is positioned to support brain health advances worldwide.

The team combines advanced AI technology with deep domain knowledge in neuroscience and pharmaceutical research to innovate neurotechnology solutions grounded in scientific rigor and focused on patient outcomes.

Beacon Biosignals is committed to accelerating neuroscience innovation, clinical development, and drug development for unmet medical needs, with a mission to bring life-changing treatments to patients faster through precision neuroscience and AI-driven biomarker technology.